• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用流式细胞术检测细胞内 IgD 可能是诊断 IgD 多发性骨髓瘤的一种新颖且补充的方法。

Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma.

机构信息

Hematology Department, China-Japan Friendship Hospital, Ying-Hua-Yuan East Street, No. 2, Beijing, 100029, China.

出版信息

BMC Cancer. 2018 Jun 11;18(1):650. doi: 10.1186/s12885-018-4562-8.

DOI:10.1186/s12885-018-4562-8
PMID:29890944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5996556/
Abstract

BACKGROUND

We examined whether detecting the heavy chain of cytoplasmic immunoglobulin D (IgD) by flow cytometry could be used as a supplemental method to diagnose IgD multiple myeloma (MM).

METHODS

Bone marrow (BM) samples of thirty-five patients with MM were collected. Five of them were IgD MM, the rest of thirty were other subtypes of MM. Antibodies to four types of heavy chains of immunoglobulin (e.g., IgA, IgG, IgM, and IgD) were analyzed by flow cytometry in each patient's BM sample.

RESULTS

The five IgD MM patients were all positive for cytoplasmic IgD. The percentage of IgD positive MM cells among nucleated cells varied from 0.4 to 12.9%. Cytoplasmic IgG was positive in eight patients with IgG MM (n = 9); cytoplasmic IgA was positive in all patients with IgA MM (n = 10); cytoplasmic IgM was positive in one patient with IgM MM (n = 1). No heavy chain was detected in light chain MM (n = 9) and non-secretory subtype (n = 1).

CONCLUSIONS

Detection of cytoplasmic IgD by flow cytometry is a convenient, sensitive and supplemental method to diagnose IgD MM.

摘要

背景

我们研究了通过流式细胞术检测免疫球蛋白 D(IgD)重链是否可作为诊断 IgD 多发性骨髓瘤(MM)的辅助方法。

方法

采集 35 例 MM 患者的骨髓(BM)样本。其中 5 例为 IgD MM,其余 30 例为其他 MM 亚型。对每位患者 BM 样本中的四种免疫球蛋白重链(如 IgA、IgG、IgM 和 IgD)进行流式细胞术分析。

结果

5 例 IgD MM 患者均为细胞质 IgD 阳性。核细胞中 IgD 阳性 MM 细胞的百分比为 0.4%至 12.9%。8 例 IgG MM 患者的细胞质 IgG 阳性(n=9);10 例 IgA MM 患者的细胞质 IgA 均阳性(n=10);1 例 IgM MM 患者的细胞质 IgM 阳性(n=1)。轻链 MM(n=9)和非分泌型(n=1)未检测到重链。

结论

流式细胞术检测细胞质 IgD 是诊断 IgD MM 的一种方便、敏感和辅助方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f44/5996556/436ce8c035ee/12885_2018_4562_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f44/5996556/36858ed225ee/12885_2018_4562_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f44/5996556/ec63c640d250/12885_2018_4562_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f44/5996556/436ce8c035ee/12885_2018_4562_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f44/5996556/36858ed225ee/12885_2018_4562_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f44/5996556/ec63c640d250/12885_2018_4562_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f44/5996556/436ce8c035ee/12885_2018_4562_Fig3_HTML.jpg

相似文献

1
Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma.使用流式细胞术检测细胞内 IgD 可能是诊断 IgD 多发性骨髓瘤的一种新颖且补充的方法。
BMC Cancer. 2018 Jun 11;18(1):650. doi: 10.1186/s12885-018-4562-8.
2
Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.伴有λ型单克隆IgG和IgD的多发性骨髓瘤,在治疗过程中,呈现出从主要为IgG向主要为IgD的转变。
Immunology. 1985 May;55(1):45-57.
3
Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies.采用全血裂解技术通过流式细胞术分析表面和细胞质免疫球蛋白轻/重链:对B细胞恶性肿瘤鉴别诊断的意义
Neoplasma. 2004;51(6):422-30.
4
IgD myeloma or delta heavy-chain disease?IgD骨髓瘤还是δ重链病?
Clin Chem. 1980 Feb;26(2):353-4.
5
A case report of biclonal immunoglobulin D lambda/lambda multiple myeloma in patient with liver echinococcosis.肝包虫病患者的双克隆免疫球蛋白 D 入/入型多发性骨髓瘤 1 例报告。
Biochem Med (Zagreb). 2024 Jun 15;34(2):020801. doi: 10.11613/BM.2024.020801. Epub 2024 Apr 15.
6
A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.一例 IgD 型骨髓瘤代表了先前诊断为 IgA-λ 型骨髓瘤患者中漏检的双克隆副蛋白血症或同种型转换。
Clin Chim Acta. 2013 Oct 21;425:233-5. doi: 10.1016/j.cca.2013.08.004. Epub 2013 Aug 13.
7
Unusual myelomas: a review of IgD and IgE variants.罕见骨髓瘤:IgD 和 IgE 变异体的综述。
Oncology (Williston Park). 2013 Aug;27(8):798-803.
8
IgD multiple myeloma. Review of 133 cases.IgD型多发性骨髓瘤。133例病例回顾。
Arch Intern Med. 1975 Jan;135(1):87-93.
9
Immunoglobulin D myeloma--problems with diagnosing and staging (own experience and literature review).免疫球蛋白D型骨髓瘤——诊断与分期问题(个人经验及文献综述)
Leuk Lymphoma. 2005 Jul;46(7):1029-37. doi: 10.1080/00268970500096442.
10
[A further case of IgD myeloma (author's transl)].IgD 骨髓瘤的另一病例(作者译)
Sem Hop. 1979;55(41-42):1941-3.

引用本文的文献

1
Uncommon Entities, Uncommon Challenges: A Review of Rare Plasma Cell Disorders.罕见病种,罕见挑战:罕见浆细胞疾病综述
Hematol Rep. 2025 Jun 27;17(4):31. doi: 10.3390/hematolrep17040031.
2
Clinical characteristics and survival of patients with IgD multiple myeloma.IgD型多发性骨髓瘤患者的临床特征与生存情况
Blood Sci. 2021 Apr 27;3(2):57-58. doi: 10.1097/BS9.0000000000000066. eCollection 2021 Apr.
3
Analysis of Serum IgG1 to Predict Progression and Therapeutic Effect in Patients with Multiple Myeloma.分析血清IgG1以预测多发性骨髓瘤患者的病情进展和治疗效果。

本文引用的文献

1
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.正常浆细胞与骨髓瘤浆细胞的免疫表型:迈向多发性骨髓瘤微小残留病检测的抗体组合规范。
Cytometry B Clin Cytom. 2016 Jan;90(1):61-72. doi: 10.1002/cyto.b.21265. Epub 2015 Jul 31.
2
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.国际骨髓瘤工作组更新了多发性骨髓瘤的诊断标准。
Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
3
Unusual myelomas: a review of IgD and IgE variants.
J Oncol. 2022 Mar 17;2022:8628781. doi: 10.1155/2022/8628781. eCollection 2022.
4
A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing.环状 RNA 结合蛋白 HNRNPU 编码的一种新型蛋白通过调控骨髓微环境和可变剪接促进多发性骨髓瘤进展。
J Exp Clin Cancer Res. 2022 Mar 8;41(1):85. doi: 10.1186/s13046-022-02276-7.
罕见骨髓瘤:IgD 和 IgE 变异体的综述。
Oncology (Williston Park). 2013 Aug;27(8):798-803.
4
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.IgD 和 IgM 多发性骨髓瘤患者行自体造血干细胞移植的结局:CIBMTR 的一项回顾性研究。
Clin Lymphoma Myeloma Leuk. 2010 Dec;10(6):458-63. doi: 10.3816/CLML.2010.n.078.
5
Efficacy and outcome of autologous transplantation in rare myelomas.自体移植在罕见骨髓瘤中的疗效和结果。
Haematologica. 2010 Dec;95(12):2126-33. doi: 10.3324/haematol.2010.022848. Epub 2010 Oct 22.
6
Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients.免疫球蛋白 D 型多发性骨髓瘤:75 例患者的治疗反应、生存情况和预后因素。
Ann Oncol. 2011 Feb;22(2):411-6. doi: 10.1093/annonc/mdq393. Epub 2010 Aug 2.
7
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.国际骨髓瘤工作组关于多发性骨髓瘤及相关疾病血清游离轻链分析的指南。
Leukemia. 2009 Feb;23(2):215-24. doi: 10.1038/leu.2008.307. Epub 2008 Nov 20.
8
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.单克隆丙种球蛋白病、多发性骨髓瘤及相关疾病的分类标准:国际骨髓瘤工作组报告
Br J Haematol. 2003 Jun;121(5):749-57.
9
The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression.生发中心中IgD骨髓瘤细胞的正常对应物表现出广泛突变的IgVH基因、Cmu-Cdelta转换和λ轻链表达。
J Exp Med. 1998 Apr 20;187(8):1169-78. doi: 10.1084/jem.187.8.1169.
10
Multiple myeloma.多发性骨髓瘤
N Engl J Med. 1997 Jun 5;336(23):1657-64. doi: 10.1056/NEJM199706053362307.